SR9009 Capsules

$30.00

Chemical Information and Compositions of SR9009 Capsules

For researchers, biochemists, and wholesale distributors, the molecular structure of sr9009 capsules is a masterpiece of targeted nuclear receptor agonism. Understanding its composition is vital for analytical testing, formulation, and predicting its biological behavior.

Official Chemical Nomenclature

  • Chemical Name: 3-(((4-Chlorophenyl)thio)methyl)-2-(4-nitrophenyl)propionic acid methyl ester
  • Chemical Formula: C20H20ClNO4S (Note: the active acid form is C19H18ClNO4S, but it is almost exclusively formulated and sold as the methyl ester prodrug).
  • Molecular Weight: 395.90 g/mol
  • CAS Number: 1379686-30-2

Structural Composition Breakdown

sr9009 capsules contain SR9009 as a methyl ester prodrug. Its structural architecture is precisely tailored to fit the ligand-binding domain (LBD) of the Rev-Erbα receptor:

  1. The Thiophene Sulfide Bridge: A critical component is the sulfur atom linking the two main aromatic systems. This thioether bond contributes to the molecule’s electron density and its precise spatial orientation within the receptor pocket, facilitating the conformational change required for Rev-Erbα repression.
  2. The 4-Chlorophenyl Group: The inclusion of a chlorine atom on the distal phenyl ring is a classic medicinal chemistry optimization. The high electronegativity and lipophilicity of the chlorine atom increase the molecule’s metabolic stability and receptor affinity.
  3. The 4-Nitrophenyl Group: The nitro group on the opposing phenyl ring is essential for the molecule’s interaction with the Rev-Erbα receptor’s helix 11 and 12, driving its high binding specificity.
  4. The Methyl Ester Prodrug: SR9009 in its free acid form has exceptionally poor oral bioavailability. To bypass this, it is synthesized as the methyl ester. Once absorbed, endogenous esterases cleave the methyl ester, releasing the active SR9009 acid into the bloodstream.

Physical and Chemical Properties

  • State at Room Temperature: Solid (Crystalline Powder)
  • Color: White to off-white
  • Solubility: Practically insoluble in water; freely soluble in DMSO, PEG 400, ethanol, and methanol. Its poor aqueous solubility necessitates specific excipient matrices for oral capsule formulation.
  • Melting Point: Approximately 70°C to 74°C.

Pharmacokinetics

  • Route of Administration: Oral
  • Absorption: This is the primary limitation of sr9009 capsules. Oral bioavailability in mammalian models is notoriously low (estimated at <5-10%) due to extensive first-pass metabolism and poor intestinal permeability.
  • Half-Life: The terminal elimination half-life is extremely short—estimated at 2 to 4 hours in humans. This necessitates a demanding dosing protocol of 3 to 4 times daily to maintain stable receptor occupancy.
  • Metabolism: Rapidly and extensively metabolized in the liver.
  • Excretion: Excreted primarily via the feces through biliary elimination.

Formulation Details: The SR9009 Capsules

When you source wholesale sr9009 capsules, you are dealing with a micro-dose formulation and a notoriously difficult API. Standard research doses range from 10mg to 40mg daily.

Because 10mg equals 0.010 grams, standard excipients used in the encapsulation process include:

  • Microcrystalline Cellulose (MCC): Filler to provide bulk.
  • Magnesium Stearate: Lubricant for encapsulation flow.
  • Hypromellose (HPMC): For vegetarian capsule shells.
  • Solubility Enhancers (e.g., PVP or SLS): Given SR9009’s poor aqueous solubility, advanced formulations often include surfactants to improve dissolution rates in the gastric fluid.

For B2B buyers, ensuring the uniform blending of such a microscopic amount of API within the excipient matrix via geometric dilution is critical. Because sr9009 capsules alter metabolic pathways, “hot spots” (capsules containing 80mg+) in a poorly blended batch can severely disrupt glucose dynamics and induce extreme lethargy.

SKU: N/A Category: